Literature DB >> 19713255

The reproducibility of Stewart parameters for acid-base diagnosis using two central laboratory analyzers.

Ba-Vinh Nguyen1, Jean-Louis Vincent, Jean Baptiste Hamm, Jean-Hervé Abalain, Jean-Luc Carre, Emmanuel Nowak, Mehdi Ould Ahmed, Charles C Arvieux, Gildas Gueret.   

Abstract

BACKGROUND: Acid-base derangements can be interpreted using the Stewart-Fencl approach, which includes calculation of the apparent strong ion difference (SID(app)), the effective SID (SID(eff)), and the strong ion gap (SIG). These calculations require the measurement of several variables. We hypothesized that the SID and SIG calculated by different analyzers would not be reproducible because of variability in the measured values.
METHODS: In this prospective observational study conducted in a biochemistry laboratory, we analyzed 179 routine blood samples from consecutive patients over a 3-mo period using two automated blood chemistry analyzers, the LX20 (Beckman) and the Modular (Roche). Measured and calculated parameters from the two analyzers were compared.
RESULTS: Although the correlation between measured values was satisfactory, there were large differences in the limits of agreement for calculated values (SID(app): 9.6 mEq/L, SID(eff): 6.4 mEq/L, and SIG: 11.7 mEq/L) and a weak correlation (SID(app): r(2) = 0.54 and SIG: r(2) = 0.12) between the analyzers.
CONCLUSIONS: The results of the Stewart-Fencl approach for interpretation of acid-base status can vary according to the analyzer used. These differences may have important clinical and research implications..

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713255     DOI: 10.1213/ANE.0b013e3181b62664

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Has Stewart approach improved our ability to diagnose acid-base disorders in critically ill patients?

Authors:  Fabio D Masevicius; Arnaldo Dubin
Journal:  World J Crit Care Med       Date:  2015-02-04

2.  The repeatability of Stewart's parameters and anion gap in a cohort of critically ill adult patients.

Authors:  Jihad Mallat; Stéphanie Barrailler; Malcolm Lemyze; Younes Benzidi; Florent Pepy; Gaëlle Gasan; Laurent Tronchon; Didier Thevenin
Journal:  Intensive Care Med       Date:  2012-08-25       Impact factor: 17.440

Review 3.  [Practical diagnostics of acid-base disorders. Part II: Complex metabolic disturbances].

Authors:  P Deetjen; M Lichtwarck-Aschoff
Journal:  Anaesthesist       Date:  2012-12       Impact factor: 1.041

4.  A simplified quantitative acid-base approach for patients with acute respiratory diseases.

Authors:  Michalis Agrafiotis; Maria Papathanassiou; Christos Karachristos; Eleni Kerezidou; Stavros Tryfon; Evangelia Serasli; Diamantis Chloros
Journal:  J Clin Monit Comput       Date:  2019-04-05       Impact factor: 2.502

5.  Use of sodium-chloride difference and corrected anion gap as surrogates of Stewart variables in critically ill patients.

Authors:  Jihad Mallat; Stéphanie Barrailler; Malcolm Lemyze; Florent Pepy; Gaëlle Gasan; Laurent Tronchon; Didier Thevenin
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

6.  Acid-base disturbances in nephrotic syndrome: analysis using the CO2/HCO3 method (traditional Boston model) and the physicochemical method (Stewart model).

Authors:  Tomomichi Kasagi; Hirokazu Imai; Naoto Miura; Keisuke Suzuki; Masabumi Yoshino; Hironobu Nobata; Takuhito Nagai; Shogo Banno
Journal:  Clin Exp Nephrol       Date:  2017-03-13       Impact factor: 2.801

Review 7.  Traditional approach versus Stewart approach for acid-base disorders: Inconsistent evidence.

Authors:  Satoshi Kimura; Muhammad Shabsigh; Hiroshi Morimatsu
Journal:  SAGE Open Med       Date:  2018-09-25

8.  Agreement of 2 electrolyte analyzers for identifying electrolyte and acid-base disorders in sick horses.

Authors:  Diego E Gomez; Sébastien Buczinski; Shannon Darby; Megan Palmisano; Sarah S K Beatty; Robert J Mackay
Journal:  J Vet Intern Med       Date:  2020-09-23       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.